title: Could increasing the duration of triple therapy be a clinically useful strategy?
authors.forename: Xavier
authors.initials: X
authors.lastname: Calvet
authors.forename: Albert
authors.initials: A
authors.lastname: Villoria
authors.forename: Mercedes
authors.initials: M
authors.lastname: Vergara
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D004334:Drug Administration Schedule; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D054328:Proton Pump Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors